<p>在过去一周，Numans Health Food Holdings (HKG:2530) 的股价下跌了 11%，因此很容易忽视它。考虑到股价通常是由公司的基本面驱动的，而在这种情况下基本面看起来相当疲弱，我们决定研究该公司的关键财务指标。具体来说，我们决定在本文中研究 Numans Health Food Holdings 的股本回报率（ROE）。</p>
<p>股本回报率（ROE）是评估公司如何有效地利用股东投资产生回报的有用工具。简而言之，ROE 显示每一美元的股东投资所产生的利润。</p>
<p>我们发现 21 只美国股票预计明年将支付超过 6% 的股息收益率。查看完整列表，免费获取。</p>
<h2>ROE 是如何计算的？</h2>
<p><strong>股本回报率可以通过以下公式计算：</strong></p>
<p>股本回报率 = 净利润（来自持续经营）÷ 股东权益</p>
<p>因此，根据上述公式，Numans Health Food Holdings 的 ROE 为：</p>
<p>6.4% = CN¥3200 万 ÷ CN¥4.96 亿（基于截至 2025 年 6 月的过去十二个月）。</p>
<p>“回报” 是指过去十二个月的税后收益。可以这样理解：对于每 HK$1 的股东资本，公司赚取了 HK$0.06 的利润。</p>
<p>查看我们对 Numans Health Food Holdings 的最新分析</p>
<h2>为什么 ROE 对盈利增长很重要？</h2>
<p>我们已经确定 ROE 是评估公司未来盈利的有效利润生成指标。根据公司再投资或 “保留” 这些利润的程度，以及其有效性，我们能够评估公司的盈利增长潜力。一般来说，其他条件相同，具有高股本回报率和利润保留的公司，其增长率高于没有这些特征的公司。</p>
<h2>Numans Health Food Holdings 的盈利增长与 6.4% ROE 的并列比较</h2>
<p>乍一看，Numans Health Food Holdings 的 ROE 并不值得一提。进一步研究显示，该公司的 ROE 与行业平均水平 11% 相比也不太理想。在这种情况下，Numans Health Food Holdings 在过去五年中净收入下降 19% 并不令人惊讶。我们认为这里可能还有其他因素在起作用。例如，可能是公司资本配置不当，或者公司有非常高的派息比率。</p>
<p>然而，当我们将 Numans Health Food Holdings 的增长与行业进行比较时，我们发现尽管公司的盈利在缩减，但行业在同一时期的盈利增长达到了 14%。这相当令人担忧。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/1912851213-past-earnings-growth-1-dark-2/1768260992308?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/1912851213-past-earnings-growth-1-dark-2/1768260992308"/></p>
<p>SEHK:2530 过去的盈利增长 2026 年 1 月 12 日</p>
<p>盈利增长是评估股票价值时需要考虑的重要指标。投资者接下来需要确定预期的盈利增长或缺乏盈利增长是否已经反映在股价中。通过这样做，他们将能够判断股票是朝着清澈的水域前进，还是面临泥泞的水域。如果你想了解 Numans Health Food Holdings 的估值，请查看其市盈率与行业的比较。</p>
<h2>Numans Health Food Holdings 是否有效地再投资其利润？</h2>
<p>考虑到公司将大部分利润用于支付股息，Numans Health Food Holdings 盈利下降并不令人惊讶，依据其三年中位派息比率为 76%（或保留比率为 24%）。公司仅剩下少量资本用于再投资——这是一种对公司长期不利的恶性循环。要了解我们为 Numans Health Food Holdings 确定的 4 个风险，请访问我们的风险仪表板，免费获取。</p>
<p>此外，Numans Health Food Holdings 最近才开始支付股息，因此管理层可能认为股东更喜欢股息，尽管盈利在缩减。</p>
<h2>结论</h2>
<p>总体而言，在对 Numans Health Food Holdings 做出任何决策之前，我们会非常谨慎。由于公司没有将太多资金再投资于业务，加上 ROE 较低，看到其盈利缺乏或没有增长并不令人惊讶。到目前为止，我们仅对公司的盈利增长进行了快速讨论。要进一步了解 Numans Health Food Holdings 过去的利润增长，请查看过去盈利、收入和现金流的可视化。</p>

纽曼思

<p>纽曼思健康食品控股（HKG:2530）股价下跌了 11%，原因归咎于基本面疲弱。该公司的股本回报率（ROE）为 6.4%，显著低于行业平均水平的 11%。在过去五年中，净收入下降了 19%，而行业则增长了 14%。76% 的高分红支付比率限制了对业务的再投资，导致盈利停滞。由于公司低 ROE 和缺乏增长潜力，投资者应保持谨慎</p>

<p>With its stock down 11% over the past week, it is easy to disregard Numans Health Food Holdings (HKG:2530). Given that stock prices are usually driven by a company’s fundamentals over the long term, which in this case look pretty weak, we decided to study the company's key financial indicators. Specifically, we decided to study Numans Health Food Holdings' ROE in this article.</p>
<div class="lb-trans"><p>在过去一周，Numans Health Food Holdings (HKG:2530) 的股价下跌了 11%，因此很容易忽视它。考虑到股价通常是由公司的基本面驱动的，而在这种情况下基本面看起来相当疲弱，我们决定研究该公司的关键财务指标。具体来说，我们决定在本文中研究 Numans Health Food Holdings 的股本回报率（ROE）。</p>
</div><p>ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. In short, ROE shows the profit each dollar generates with respect to its shareholder investments.</p>
<div class="lb-trans"><p>股本回报率（ROE）是评估公司如何有效地利用股东投资产生回报的有用工具。简而言之，ROE 显示每一美元的股东投资所产生的利润。</p>
</div><p>We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.</p>
<div class="lb-trans"><p>我们发现 21 只美国股票预计明年将支付超过 6% 的股息收益率。查看完整列表，免费获取。</p>
</div><h2>How Is ROE Calculated?</h2>
<div class="lb-trans"><h2>ROE 是如何计算的？</h2>
</div><p><strong>Return on equity can be calculated by using the formula:</strong></p>
<div class="lb-trans"><p><strong>股本回报率可以通过以下公式计算：</strong></p>
</div><p>Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity</p>
<div class="lb-trans"><p>股本回报率 = 净利润（来自持续经营）÷ 股东权益</p>
</div><p>So, based on the above formula, the ROE for Numans Health Food Holdings is:</p>
<div class="lb-trans"><p>因此，根据上述公式，Numans Health Food Holdings 的 ROE 为：</p>
</div><p>6.4% = CN¥32m ÷ CN¥496m (Based on the trailing twelve months to June 2025).</p>
<div class="lb-trans"><p>6.4% = CN¥3200 万 ÷ CN¥4.96 亿（基于截至 2025 年 6 月的过去十二个月）。</p>
</div><p>The 'return' is the amount earned after tax over the last twelve months. One way to conceptualize this is that for each HK$1 of shareholders' capital it has, the company made HK$0.06 in profit.</p>
<div class="lb-trans"><p>“回报” 是指过去十二个月的税后收益。可以这样理解：对于每 HK$1 的股东资本，公司赚取了 HK$0.06 的利润。</p>
</div><p>View our latest analysis for Numans Health Food Holdings</p>
<div class="lb-trans"><p>查看我们对 Numans Health Food Holdings 的最新分析</p>
</div><h2>Why Is ROE Important For Earnings Growth?</h2>
<div class="lb-trans"><h2>为什么 ROE 对盈利增长很重要？</h2>
</div><p>We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. Depending on how much of these profits the company reinvests or &#34;retains&#34;, and how effectively it does so, we are then able to assess a company’s earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don’t share these attributes.</p>
<div class="lb-trans"><p>我们已经确定 ROE 是评估公司未来盈利的有效利润生成指标。根据公司再投资或 “保留” 这些利润的程度，以及其有效性，我们能够评估公司的盈利增长潜力。一般来说，其他条件相同，具有高股本回报率和利润保留的公司，其增长率高于没有这些特征的公司。</p>
</div><h2>A Side By Side comparison of Numans Health Food Holdings' Earnings Growth And 6.4% ROE</h2>
<div class="lb-trans"><h2>Numans Health Food Holdings 的盈利增长与 6.4% ROE 的并列比较</h2>
</div><p>On the face of it, Numans Health Food Holdings' ROE is not much to talk about. A quick further study shows that the company's ROE doesn't compare favorably to the industry average of 11% either. Given the circumstances, the significant decline in net income by 19% seen by Numans Health Food Holdings over the last five years is not surprising. We reckon that there could also be other factors at play here. For example, it is possible that the business has allocated capital poorly or that the company has a very high payout ratio.</p>
<div class="lb-trans"><p>乍一看，Numans Health Food Holdings 的 ROE 并不值得一提。进一步研究显示，该公司的 ROE 与行业平均水平 11% 相比也不太理想。在这种情况下，Numans Health Food Holdings 在过去五年中净收入下降 19% 并不令人惊讶。我们认为这里可能还有其他因素在起作用。例如，可能是公司资本配置不当，或者公司有非常高的派息比率。</p>
</div><p>However, when we compared Numans Health Food Holdings' growth with the industry we found that while the company's earnings have been shrinking, the industry has seen an earnings growth of 14% in the same period. This is quite worrisome.</p>
<div class="lb-trans"><p>然而，当我们将 Numans Health Food Holdings 的增长与行业进行比较时，我们发现尽管公司的盈利在缩减，但行业在同一时期的盈利增长达到了 14%。这相当令人担忧。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/asset/chart/1912851213-past-earnings-growth-1-dark-2/1768260992308" alt="" original-src="https://images.simplywall.st/asset/chart/1912851213-past-earnings-growth-1-dark-2/1768260992308"/></p>
<p>SEHK:2530 Past Earnings Growth January 12th 2026</p>
<div class="lb-trans"><p>SEHK:2530 过去的盈利增长 2026 年 1 月 12 日</p>
</div><p>Earnings growth is an important metric to consider when valuing a stock. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. If you're wondering about Numans Health Food Holdings''s valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.</p>
<div class="lb-trans"><p>盈利增长是评估股票价值时需要考虑的重要指标。投资者接下来需要确定预期的盈利增长或缺乏盈利增长是否已经反映在股价中。通过这样做，他们将能够判断股票是朝着清澈的水域前进，还是面临泥泞的水域。如果你想了解 Numans Health Food Holdings 的估值，请查看其市盈率与行业的比较。</p>
</div><h2>Is Numans Health Food Holdings Efficiently Re-investing Its Profits?</h2>
<div class="lb-trans"><h2>Numans Health Food Holdings 是否有效地再投资其利润？</h2>
</div><p>Numans Health Food Holdings' declining earnings is not surprising given how the company is spending most of its profits in paying dividends, judging by its three-year median payout ratio of 76% (or a retention ratio of 24%). The business is only left with a small pool of capital to reinvest - A vicious cycle that doesn't benefit the company in the long-run. To know the 4 risks we have identified for Numans Health Food Holdings visit our risks dashboard for free.</p>
<div class="lb-trans"><p>考虑到公司将大部分利润用于支付股息，Numans Health Food Holdings 盈利下降并不令人惊讶，依据其三年中位派息比率为 76%（或保留比率为 24%）。公司仅剩下少量资本用于再投资——这是一种对公司长期不利的恶性循环。要了解我们为 Numans Health Food Holdings 确定的 4 个风险，请访问我们的风险仪表板，免费获取。</p>
</div><p>In addition, Numans Health Food Holdings only recently started paying a dividend so the management probably decided the shareholders prefer dividends even though earnings have been shrinking.</p>
<div class="lb-trans"><p>此外，Numans Health Food Holdings 最近才开始支付股息，因此管理层可能认为股东更喜欢股息，尽管盈利在缩减。</p>
</div><h2>Conclusion</h2>
<div class="lb-trans"><h2>结论</h2>
</div><p>Overall, we would be extremely cautious before making any decision on Numans Health Food Holdings. Because the company is not reinvesting much into the business, and given the low ROE, it's not surprising to see the lack or absence of growth in its earnings. So far, we've only made a quick discussion around the company's earnings growth. To gain further insights into Numans Health Food Holdings' past profit growth, check out this visualization of past earnings, revenue and cash flows.</p>
<div class="lb-trans"><p>总体而言，在对 Numans Health Food Holdings 做出任何决策之前，我们会非常谨慎。由于公司没有将太多资金再投资于业务，加上 ROE 较低，看到其盈利缺乏或没有增长并不令人惊讶。到目前为止，我们仅对公司的盈利增长进行了快速讨论。要进一步了解 Numans Health Food Holdings 过去的利润增长，请查看过去盈利、收入和现金流的可视化。</p>
</div>

纽曼思健康食品控股有限公司（HKG:2530）的股票正在下跌：是否是由于基本面不佳所致？